BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37152485)

  • 1. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.
    Laughlin BS; Ebrahimi S; Voss MM; Patel SH; Foote RL; McGee LA; Garcia J; Ma DJ; Garces YI; Wittich MAN; Price KA; Schmitt A; Zhai Q; May BC; Nagel TH; Hinni ML; Chintakuntlawar AV; DeWees TA; Rwigema JM
    Adv Radiat Oncol; 2023; 8(4):101204. PubMed ID: 37152485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
    Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
    J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.
    Kim JY; Lee S; Cho KJ; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Shin HS; Chang SK; Ahn SD
    Br J Radiol; 2012 Oct; 85(1018):e947-52. PubMed ID: 22573301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
    Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
    Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.
    Wei J; Tan YT; Cai YC; Yuan ZY; Yang D; Wang SS; Peng RJ; Teng XY; Liu DG; Shi YX
    Chin J Cancer; 2014 Oct; 33(10):492-500. PubMed ID: 25104281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.
    Cassidy RJ; Switchenko JM; Jegadeesh N; Sayan M; Ferris MJ; Eaton BR; Higgins KA; Wadsworth JT; Magliocca KR; Saba NF; Beitler JJ
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):382-388. PubMed ID: 28097311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes of patients with salivary gland cancer treated with surgery and postoperative intensity-modulated radiotherapy: a retrospective cohort study.
    Zang S; Chen M; Huang H; Zhu X; Li X; Yan D; Yan S
    Quant Imaging Med Surg; 2022 May; 12(5):2841-2854. PubMed ID: 35502385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
    Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience.
    Jethwa KR; Day CN; Sandhyavenu H; Gonuguntla K; Harmsen WS; Breen WG; Routman DM; Garda AE; Hubbard JM; Halfdanarson TR; Neben-Wittich MA; Merrell KW; Hallemeier CL; Haddock MG
    Clin Transl Radiat Oncol; 2021 May; 28():17-23. PubMed ID: 33732911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
    Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
    HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in postoperative radiotherapy in salivary gland carcinoma: A single institution experience from Turkey.
    Kandaz M; Soydemir G; Bahat Z; Canyılmaz E; Yöney A
    Indian J Cancer; 2016; 53(2):274-279. PubMed ID: 28071626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.
    Al-Jumayli M; Batool A; Middiniti A; Saeed A; Sun W; Al-Rajabi R; Baranda J; Kumer S; Schmitt T; Chidharla A; Kasi A
    J Oncol; 2019; 2019():3293509. PubMed ID: 31186632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
    Moekotte AL; Lof S; Van Roessel S; Fontana M; Dreyer S; Shablak A; Casciani F; Mavroeidis VK; Robinson S; Khalil K; Gradinariu G; Mowbray N; Al-Sarireh B; Fusai GK; Roberts K; White S; Soonawalla Z; Jamieson NB; Salvia R; Besselink MG; Abu Hilal M
    Ann Surg; 2020 Dec; 272(6):1086-1093. PubMed ID: 30628913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine carcinosarcoma: A 10-year single institution experience.
    Terblanche L; Botha MH
    PLoS One; 2022; 17(7):e0271526. PubMed ID: 35862371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.